Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64(24):e139–e228
Article
Google Scholar
Guha S, Sethi R, Ray S, Bahl VK, Shanmugasundaram S, Kerkar P et al (2017) Cardiological Society of India: position statement for the management of ST elevation myocardial infarction in India. Indian Heart J 69(Suppl 1):S63–S97
Article
Google Scholar
Bhagwat MM, Woods JA, Dronavalli M, Hamilton SJ, Thompson SC (2016) Evidence-based interventions in primary care following acute coronary syndrome in Australia and New Zealand: a systematic scoping review. BMC Cardiovasc Disord 16(1):214
Article
Google Scholar
Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D et al (2010) Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol 56(4):254–263
Article
Google Scholar
Tobbia P, Brodie BR, Witzenbichler B, Metzger C, Guagliumi G, Yu J et al (2013) Adverse event rates following primary PCI for STEMI at US and non-US hospitals: 3-year analysis from the HORIZONS-AMI trial. EuroIntervention 8(10):1134–1142
Article
Google Scholar
Jones K, Saxon L, Cunningham W, Adams P, Guideline Development Group (2013) Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance. BMJ 347:f6544
Article
Google Scholar
Fox KA (2004) Management of acute coronary syndromes: an update. Heart 90(6):698–706
Article
Google Scholar
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al (2002) American College of Cardiology; American Heart Association. Committee on the Management of Patients with Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40(7):1366–1374
Article
Google Scholar
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al (2018) ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177
Article
Google Scholar
Simms AD, Weston CF, West RM, Hall AS, Batin PD, Timmis A et al (2015) Mortality and missed opportunities along the pathway of care for ST-elevation myocardial infarction: a national cohort study. Eur Heart J Acute Cardiovasc Care 4(3):241–253
Article
CAS
Google Scholar
Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS et al (2008) CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 371(9622):1435–1442
Article
Google Scholar
Bramlage P, Messer C, Bitterlich N, Pohlmann C, Cuneo A, Stammwitz E et al (2010) The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart 96(8):604–609
Article
CAS
Google Scholar
Nassr OA, Forsyth P, Johnson CF (2019) Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq. Pharm Pract (Granada) 17(1):1372
Article
Google Scholar
Kytö V, Prami T, Khanfir H, Hasvold P, Reissell E, Airaksinen J (2019) Usage of PCI and long-term cardiovascular risk in post-myocardial infarction patients: a nationwide registry cohort study from Finland. BMC Cardiovasc Disord 19(1):123
Article
Google Scholar
Makam RC, Erskine N, McManus DD, Lessard D, Gore JM, Yarzebski J et al (2016) Decade-long trends (2001 to 2011) in the use of evidence-based medical therapies at the time of hospital discharge for patients surviving acute myocardial infarction. Am J Cardiol 118(12):1792–1797
Article
Google Scholar
Lee HY, Cooke CE, Robertson TA (2008) Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm 14(3):271–280
Article
Google Scholar
Al-Zakwani I, Zubaid M, Panduranga P, Rashed W, Sulaiman K, Almahmeed W et al (2011) Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events. Angiology 62(6):447–454
Article
Google Scholar
Vermeer NS, Bajorek BV (2008) Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. J Clin Pharm Ther 33(6):591–601
Article
CAS
Google Scholar
Kassab YW, Hassan Y, Aziz NA, Akram H, Ismail O (2013) Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice. J Eval Clin Pract 19(4):658–663
Article
Google Scholar
Byeon HJ, Yang YM, Choi EJ (2016) Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea. Ther Clin Risk Manag 12:167–175
CAS
PubMed
PubMed Central
Google Scholar
Quilliam BJ (2008) Suboptimal utilization of secondary drug prevention in acute coronary syndrome: measurement issues and managed care opportunities. J Manag Care Pharm 14(3):312–315
Article
Google Scholar
El Hajj MS, Jaam MJ, Awaisu A (2018) Effect of pharmacist care on medication adherence and cardiovascular outcomes among patients post-acute coronary syndrome: a systematic review. Res Social Adm Pharm 14(6):507–520
Article
Google Scholar
Jabri AM, Assad HC, Al-Jumaili AA (2020) Pharmacist role to enhance the prescribing of hospital discharge medications for patients after heart attack. Saudi Pharm J 28(4):473–479
Article
Google Scholar
Hassan Y, Kassab Y, Abd Aziz N, Akram H, Ismail O (2013) The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge. J Clin Pharm Ther 38(2):97–100
Article
CAS
Google Scholar
Esposito P, Dal Canton A (2014) Clinical audit, a valuable tool to improve quality of care: general methodology and applications in nephrology. World J Nephrol 3(4):249–255
Article
Google Scholar
Marcucci R, Patti G, Calabrò P, Gori AM, Grossi G, Cirillo P et al (2019) Antiplatelet treatment in acute coronary syndrome patients: real-world data from the START-Antiplatelet Italian Registry. PLoS ONE 14(7):e0219676
Article
CAS
Google Scholar
Kim MJ, Jeon DS, Gwon HC, Kim SJ, Chang K, Kim HS et al (2012) Korean MUSTANG Investigators. Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea. Clin Cardiol 35(11):700–706
Article
Google Scholar
Ong HT, Ong LM, Ho JJ (2013) Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in patients at high risk of cardiovascular events: a meta-analysis of 10 randomised placebo-controlled trials. ISRN Cardiol. 2013:478597
Article
Google Scholar
Bainey KR, Armstrong PW, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED et al (2014) Use of renin–angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program. Circ Cardiovasc Qual Outcomes 7(2):227–235
Article
Google Scholar
El-Hajj MS, Saad A, Al-Suwaidi J, Al-Marridi WZ, Elkhalifa DH, Mohamed AA et al (2016) Utilization of evidence-based secondary prevention medications at the time of discharge in patients with acute coronary syndrome (ACS) in Qatar. Curr Vasc Pharmacol 14(4):394–403
Article
CAS
Google Scholar
Nhat MG, Hai HN, Ngoc-Hoa C (2020) Renal kinetics in acute heart failure. Open Heart. 7(1):e001173
Article
Google Scholar
Noble S, Roffi M (2017) Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue? J Thorac Dis 9(11):4191–4194
Article
Google Scholar
Nguyen T, Nguyen HQ, Widyakusuma NN, Nguyen TH, Pham TT, Taxis K (2018) Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals. BMJ Open 8(1):e018271
Article
Google Scholar